^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    dexamethasone injection

    Associations

    News

    Trials
    Company:
    Generic mfg.
    Drug class:
    Steroid receptor agonist, GCR agonist
    Related drugs:
    Associations

    News

    Trials
    2d
    Application of Multimodal Intervention in the Prevention of Postoperative Nausea and Vomiting After Gynecological Laparoscopic Surgery (clinicaltrials.gov)
    P=N/A, N=212, Not yet recruiting, Sir Run Run Shaw Hospital
    New trial
    |
    dexamethasone injection
    2d
    Comparison of Spinal Anesthesia Adjuvant and Quadratus Lumborum Block on the Opioid Requirement and Perioperative Pain of Laparoscopic Kidney Transplant Donor (clinicaltrials.gov)
    P=N/A, N=60, Completed, Indonesia University | Recruiting --> Completed
    Trial completion
    |
    dexamethasone injection
    5d
    A Study of Daratumumab (clinicaltrials.gov)
    P3, N=500, Recruiting, Janssen Research & Development, LLC | Trial completion date: Jan 2029 --> Dec 2029
    Trial completion date
    |
    lenalidomide • Darzalex (daratumumab) • carfilzomib • pomalidomide • Darzalex Faspro (daratumumab and hyaluronidase-fihj) • dexamethasone injection
    5d
    AQUARIUS: A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis (clinicaltrials.gov)
    P2, N=151, Active, not recruiting, Janssen Research & Development, LLC | Trial primary completion date: May 2025 --> Feb 2026
    Trial primary completion date
    |
    bortezomib • cyclophosphamide • Darzalex Faspro (daratumumab and hyaluronidase-fihj) • dexamethasone injection
    7d
    MonumenTAL-6: A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide (clinicaltrials.gov)
    P3, N=795, Recruiting, Janssen Research & Development, LLC | Trial completion date: Mar 2028 --> Dec 2028
    Trial completion date
    |
    lenalidomide • bortezomib • pomalidomide • Empliciti (elotuzumab) • Talvey (talquetamab-tgvs) • Tecvayli (teclistamab-cqyv) • dexamethasone injection
    9d
    Protective Effects of Adipose-derived Stem Cell Exosomes vs Dexamethasone on Neuromotor Deficits in Focal Cerebral Ischemia. (PubMed, Basic Clin Neurosci)
    Exosomes were administered intravenously, while dexamethasone was given intraperitoneally...Their multi-modal mechanisms-including anti-inflammatory, anti-apoptotic, angiogenic, and neuroregenerative effects-highlight their potential as a novel therapeutic approach for stroke management. Future research should focus on clinical translation, dosage optimization, and long-term safety evaluation.
    Journal
    |
    IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha)
    |
    dexamethasone injection
    12d
    Dexamethasone for Ureteral STent Symptoms (DUSTS) (clinicaltrials.gov)
    P1/2, N=70, Recruiting, The Methodist Hospital Research Institute | Not yet recruiting --> Recruiting
    Enrollment open
    |
    dexamethasone injection
    12d
    Dexamethasone to Prevent Side Effects of Spinal Anesthesia in Cesarean Delivery (clinicaltrials.gov)
    P4, N=176, Enrolling by invitation, University Medical Center Ho Chi Minh City (UMC)
    New P4 trial • Adverse events
    |
    dexamethasone injection
    19d
    Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty (clinicaltrials.gov)
    P4, N=90, Completed, Poznan University of Medical Sciences | Recruiting --> Completed | Trial completion date: Oct 2026 --> Mar 2026 | Trial primary completion date: Sep 2026 --> Mar 2026
    Trial completion • Trial completion date • Trial primary completion date
    |
    dexamethasone injection
    19d
    The Effect of Dexamethasone Administration Route and Local Anesthetic Concentration on Pain, Inflammatory Response, and Neuromonitoring in Children Undergoing Scoliosis Correction (clinicaltrials.gov)
    P4, N=60, Recruiting, Poznan University of Medical Sciences | Trial completion date: Jan 2026 --> Sep 2026 | Trial primary completion date: Dec 2025 --> Jul 2026
    Trial completion date • Trial primary completion date
    |
    dexamethasone injection
    19d
    Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss (clinicaltrials.gov)
    P1/2, N=0, Withdrawn, Seoul National University Hospital | N=26 --> 0 | Not yet recruiting --> Withdrawn
    Enrollment change • Trial withdrawal
    |
    dexamethasone injection
    19d
    Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery (clinicaltrials.gov)
    P=N/A, N=150, Recruiting, Poznan University of Medical Sciences | Not yet recruiting --> Recruiting | Initiation date: Apr 2026 --> Dec 2025
    Enrollment open • Trial initiation date
    |
    dexamethasone injection